27975-48-0

Upstream product

• 106-45-6 para-thiocresol 
• 6972-09-4 4-methylbenzenesulfonic acid, 4-hydroxybutyl ester 
• 928-51-8 4-Chloro-1-butanol 
• 10486-08-5 sodium p-thiocresolate 

Downstream Products

• 17482-29-0 4-hydroxybutyl p-tolyl sulfone 
• 142128-70-9 4-(p-tolylsulfinyl)butan-1-ol 
• 14633-32-0 4-(4-methylphenylmercapto)-butylchloride 
• 1221171-41-0 4-tosyloxybutyl p-tolyl sulfoxide 
• 1221171-42-1 cyclobutyl p-tolyl sulfoxide 
• 1221171-44-3 1-chlorocyclobutyl p-tolyl sulfoxide 
• 94265-43-7 4-(p-Tolylsulfonyloxy-butyl)-mercapto-4-methylbenzol 
• 17482-30-3 1-((4-bromobutyl)sulfonyl)-4-methylbenzene 
• 42330-83-6 N-(4-p-Tolylthiobutyl)anilin 

Relevant academic research and scientific papers

Novel compound capable of activating Nrf2, and pharmaceutical compositions comprising the same

The present invention provides a novel compound which can activate Nrf2 that is a transcription factor for expression of the quinone reductase gene. Therefore the compound is effective for inhibiting apoptosis and preventing and treating brain nerve disea

Synthesis of multi-substituted cyclobutanes and alkylidenecyclobutanes by the reaction of cyclobutylmagnesium carbenoids with nucleophiles

Treatment of 1-chlorocyclobutyl p-tolyl sulfoxides with Grignard reagents such as ethylmagnesium chloride, isopropylmagnesium chloride, and cyclopentylmagnesium chloride in THF at low temperature gave cyclobutylmagnesium carbenoids in high yields. The gen